| Patient | Emily Dickinson |
|---|---|
| Date of birth | 1971-12-10 |
| Identifiers | MRN HR-NI023-SYN; SSN (made up) 000-23-6081 |
| Document date | 2026-04-20 |
| Author | Lucinda Hartwell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Vomiting and diarrhea for two days (same-day home visit). [S]
Ms. Dickinson is a 54-year-old woman with stage G3a A2 chronic kidney disease and hypertension who called this morning and was seen at home the same day. Two days ago she developed nausea, then vomiting four or five times a day and watery diarrhea six times a day; a member of her household had a similar illness last week. She has kept down only sips of water and tea since yesterday. She feels lightheaded when she stands. She has taken all her usual medicines, including losartan 100 mg, dapagliflozin 10 mg, and amlodipine 5 mg, each morning, because she did not remember the sick-day advice. She has had no blood in the stool or vomit, no severe abdominal pain, and no recent antibiotics or travel. She has taken no NSAIDs. She has passed little urine today. [S]
| Element | Detail |
|---|---|
| Onset | Two days ago, after a household contact with a similar illness |
| Severity | Vomiting four or five times and watery diarrhea six times a day; sips of fluid only |
| Associated symptoms | Lightheaded on standing; little urine today; temperature 37.6 °C |
| Medicines | Took losartan, dapagliflozin, and amlodipine every morning; no NSAIDs |
| Pertinent negatives | No blood in stool or vomit, severe abdominal pain, recent antibiotics, or travel |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired and weak; low-grade temperature; no rigors |
| Gastrointestinal | Positive | Nausea, vomiting, and watery diarrhea; mild crampy discomfort; no blood |
| Genitourinary | Positive | Passing little urine; no dysuria or flank pain |
| Cardiovascular | Negative | No chest pain or palpitations; lightheaded only on standing |
| Neurological | Negative | No confusion, headache, or fainting |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen sodium 220 mg oral tablet, two tablets by mouth as needed for headache (over the counter) | Two tablets as needed, up to twice a day | Oral route | 2025-10-01 to 2026-01-12 | stopped | S |
| Losartan 50 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 to 2026-02-02 | completed | S |
| Losartan 100 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-02-02 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 | active | S |
| Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a day | Two tablets every 6 hours as needed; maximum 6 tablets a day | Oral route | 2026-01-12 | active | S |
| Dapagliflozin 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-02-02 | active | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-02 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-20 | Body height | 163 | cm | S |
| 2026-04-20 | Body weight | 51.9 | kg | S |
| 2026-04-20 | Body mass index (BMI) [Ratio] | 19.5 | kg/m2 | S |
| 2026-04-20 | Systolic blood pressure | 104 | mm[Hg] | S |
| 2026-04-20 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 2026-04-20 | Heart rate | 102 | /min | S |
| 2026-04-20 | Respiratory rate | 18 | /min | S |
| 2026-04-20 | Body temperature | 37.6 | Cel | S |
| 2026-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-20 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-20 | Potassium [Moles/volume] in Serum or Plasma | 5.3 | mmol/L | 3.5-5.1 mmol/L | High | S |
| 2026-04-20 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 20 | mmol/L | 22-29 mmol/L | Low | S |
| 2026-04-20 | Urea nitrogen [Mass/volume] in Serum or Plasma | 34 | mg/dL | 6-21 mg/dL | High | S |
| 2026-04-20 | Creatinine [Mass/volume] in Serum or Plasma | 1.66 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 2026-04-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 36 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 2026-04-20 | Glucose [Mass/volume] in Serum or Plasma | 86 | mg/dL | 70-99 mg/dL | Normal | S |
Vital signs recorded on 2026-04-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Tired, resting in her bedroom chair; alert and oriented |
| Vital signs | Seated 104/64 mmHg, pulse 102; standing after one minute 92/58 mmHg, pulse 116, with lightheadedness; weight 51.9 kg, down 1.7 kg since the last weighing |
| Mouth | Dry mucous membranes |
| Abdomen | Soft; mild diffuse tenderness without guarding; active bowel sounds |
| Skin | Reduced skin turgor; capillary refill 3 seconds |
| Cardiovascular | Regular tachycardia; no murmur |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chronic kidney disease stage G3a A2, attributed to hypertension; synthetic modern diagnosis linked to the Bright's disease entered on her death certificate | active | confirmed | N18.31 | S — Synthetic modern diagnosis. Bright's disease as her recorded cause of death is documented (D); what it meant in her case is a retrospective question (R), and no kidney test from her lifetime exists. |
| Hypertension with chronic kidney disease (hypertensive chronic kidney disease, stage 3a); synthetic modern diagnosis linked to the retrospective view that she had severe hypertension | active | confirmed | I12.9 | S — Synthetic modern diagnosis; severe hypertension is a retrospective interpretation (R, possible), and no blood pressure from her lifetime exists. |
| Vitamin D deficiency with a mildly raised PTH in chronic kidney disease | active | confirmed | E55.9 | S — Synthetic laboratory finding at the intake visit. |
| Viral gastroenteritis with volume depletion and a prerenal rise in creatinine while taking losartan and dapagliflozin; resolved | resolved | confirmed | A08.4 | S — Synthetic illness at an unscheduled home visit, chosen to teach sick-day rules in chronic kidney disease; it does not echo any documented illness. |
Guideline basis: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, and depression monographs (2026)
Follow-up: Nurse telephone call tomorrow; repeat metabolic panel in two to three days; three-month kidney review at home in early June. Next scheduled visit 2026-06-01: home visit for the three-month kidney and blood pressure review. [S]